Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Radiat Oncol Biol Phys ; 93(3): 658-67, 2015 Nov 01.
Article in English | MEDLINE | ID: mdl-26461008

ABSTRACT

PURPOSE: To investigate the roles of radiation therapy and chemotherapy in the occurrence of subsequent leukemia after childhood cancer. METHODS AND MATERIALS: We analyzed data from a case-control study with 35 cases and 140 controls. The active bone marrow (ABM) was segmented into 19 compartments, and the radiation dose was estimated in each. The chemotherapy drug doses were also estimated to enable adjustments. Models capable of accounting for radiation dose heterogeneity were implemented for analysis. RESULTS: Univariate analysis showed a significant trend in the increase of secondary leukemia risk with radiation dose, after accounting for dose heterogeneity (P=.046). This trend became nonsignificant after adjustment for doses of epipodophyllotoxins, alkylating agents, and platinum compounds and the first cancer on multivariate analysis (P=.388). The role of the radiation dose appeared to be dwarfed, mostly by the alkylating agents (odds ratio 6.9, 95% confidence interval 1.9-25.0). Among the patients who have received >16 Gy to the ABM, the radiogenic risk of secondary leukemia was about 4 times greater in the subgroup with no alkylating agents than in the subgroup receiving ≥10 g/m(2). CONCLUSIONS: Notwithstanding the limitations resulting from the size of our study population and the quite systematic co-treatment with chemotherapy, the use of detailed information on the radiation dose distribution to ABM enabled consideration of the role of radiation therapy in secondary leukemia induction after childhood cancer.


Subject(s)
Antineoplastic Agents/adverse effects , Bone Marrow/drug effects , Bone Marrow/radiation effects , Leukemia, Radiation-Induced , Leukemia/chemically induced , Neoplasms/therapy , Adolescent , Analysis of Variance , Antineoplastic Agents, Alkylating/adverse effects , Case-Control Studies , Child , Child, Preschool , Confidence Intervals , Female , Humans , Infant , Male , Neoplasms, Second Primary/etiology , Odds Ratio , Platinum Compounds/adverse effects , Podophyllotoxin/adverse effects , Radiation Dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...